Detalhe da pesquisa
1.
Molecular and clinical diversity in primary central nervous system lymphoma.
Ann Oncol
; 34(2): 186-199, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402300
2.
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.
Ann Hematol
; 102(5): 1159-1169, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991231
3.
Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review.
Rev Neurol (Paris)
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042665
4.
CSF biomarkers in primary CNS lymphoma.
Rev Neurol (Paris)
; 179(3): 141-149, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336490
5.
Recent advances in the diagnosis and the treatment of primary CNS lymphoma.
Rev Neurol (Paris)
; 179(5): 481-489, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37045615
6.
Neurological side effects of radiation therapy.
Neurol Sci
; 43(4): 2363-2374, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149927
7.
MRI features of intra-axial histiocytic brain mass lesions.
Clin Radiol
; 76(2): 159.e19-159.e28, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077156
8.
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA).
Ann Oncol
; 30(4): 621-628, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698644
9.
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839484
10.
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study.
Ann Hematol
; 98(4): 915-922, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535802
11.
BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system.
Rev Neurol (Paris)
; 177(6): 708-710, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478735
12.
Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse.
Rev Neurol (Paris)
; 177(4): 436-439, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190919
13.
Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?
Rev Neurol (Paris)
; 172(6-7): 384-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27371132
14.
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Ann Oncol
; 26(7): 1305-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701456
15.
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
Br J Cancer
; 111(10): 2024-32, 2014 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25314060
16.
Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.
Eur J Cancer
; 202: 114004, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493668
17.
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
Br J Cancer
; 108(10): 2178-85, 2013 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23571737
18.
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.
J Neurooncol
; 115(2): 261-5, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23955572
19.
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Br J Cancer
; 104(12): 1854-61, 2011 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21610707
20.
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA.
Ann Oncol
; 27(7): 1349-50, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002105